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1. INTRODUCTION 
It has been shown that the enzymatic reduction of 
methemoglobin in mature circulating red-cells is 
promoted by a soluble form of NADH-cytochrome 
b5 reductase (EC 1.6.2.2) [ 11. Subsequent studies 
have demonstrated that this enzyme is related to the 
ubiquitous membrane-bound cytochrome bS re- 
ductase [2-41, and that both entities are encoded by 
a single gene (DIAt) located on chromosome 22 
[5,6]. In most nucleated cells -95% of the cyto 
chrome b5 reductase is bound to membranes (endo- 
plasmic reticulum, mitochondria, nuclear and 
plasma membrane) [7,8]. In contrast, in the mature 
red cell -60% of the cytochrome b5 reductase acti- 
vity is soluble 191. Accumulating evidence indi- 
cates that the soluble cytochrome b5 reductase arises 
from the membrane-bound enzyme by proteolytic 
cleavage of the hydrophobic domain of the protein 
[ 10,111. Here, we have investigated the timing of this 
post-translational process during the course of 
erythroid differentiation. The model chosen was the 
Friend murine erythroleukemic cell (MELC), in 
which we studied the activity and distribution of the 
membrane-bound and soluble cytochrome b5 re- 
ductase before and after induction by dimethyl 
sulfoxide (DMSO). 
2. MATERIALS AND METHODS 
2.1. CeN culture and induction conditions 
Friend erythroleukemic cells (clone 707 17C, 
kindly donated by Dr Adrian J. Minty, Pasteur Insti- 
tute, Paris) were grown in standard conditions 
1121. When required for induction, dimethyl sulf- 
oxide was added to 1.5% (v/v). Uninduced cultures 
in exponential phase were harvested at 7 x lo5 
cells/ml. A DMSO-resistant variant (clone TR 
25D), non-inducible for globin mRNA hemoglobin 
and spectrin [ 131, was grown in the same conditions. 
Cells were harvested by centrifugation at 600 x g 
for 10 min. Pellets were washed 2 times with 0.9% 
NaCl and immediately treated as followed. 
2.2. Preparation of cell extracts 
2.2.1. Total extracts 
The cell pellet (lo* cells) was homogenized with a 
Teflon Potter homogenizer in 0.9 ml 0.25 M sac- 
charose in a 1 mM Tris-HCl buffer (pH 7.0) 1 mM 
EDTA, 1 mM phenyl methyl sulfonyl fluoride. An 
aliquot (0.05 ml) was suspended in 0.05 ml 4% (w/v) 
Triton X-100 in water, vigorously stirred in a Vortex 
apparatus and frozen and thawed 3 times. The 
30 000 x g supernate was used for enzyme assays. 
2.2.2. Subcellular fractionation 
The homogenate was centrifuged at 800 x g for 
10 min to obtain the nuclear pellet, then at 12 000 x 
g for 15 min (mitochondrial and lysosomal pellets) 
and at 105 000 x g for 10 min (Airfuge Bechmann) 
to obtain the microsomal pellet and the cytosolic 
supernatant. The 800 x g, 12 000 x g, 105 000 x g 
pellets were suspended in 0.3 ml 4% Triton X-100, 
frozen and thawed 3 times, centrifuged at 30 000 x 
g and the supernates were used for enzyme assays. 
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Table I 
Cytochrome b5 reductase activity in MELC (clone 707 17C) and in erythroid and non-eryth- 
roid mouse cells 
Specific activity Total activity 
(nmol . min ~ ’ . mg protein - t) (nmol . min - ’ . lo8 cells - t) 
Untreated MELC 
DMSO-treated MELC 
(4 days) 
27.22 3.1 (4) 50.7 
55.9 + 11.3 (4) 161.0 
Reticulocytes 
of DBA/2 mice 
Erythrocytes 
of DBA/2 mice 
17.5 nd. 
15.0 n.d. 
n.d. = not determined 
All extracts were made in the presence of 2% Triton X- 100, as described in text, enabling to 
measure total cytochrome b5 reductase activity (soluble and membrane-bound) 
2.3. Reticulocytes and erythrocytes of DBA12 mice 
preparation 
DBA/2 mice were obtained from the Centre 
d’Elevage de la Source (Orleans). A reticulocyte en- 
riched-fraction was separated on a Percoll gradient 
[ 141 after leukocyte elimination on a cellulose col- 
umn. To estimate the soluble and membranous 
fractions of reticulocytes and erythrocytes, enzy- 
matic assays were performed without or with 2% 
final (w/v) Triton X-100. 
2.4. Assay for NADH-cytochrome bj reductase 
activity 
Activity was assayed with the ferrocyanide-met- 
hemoglobin complex as a substrate as in [15]. The 
results were expressed as pmol or nmol substrate 
reduced/mg protein or / 10’ cells. 
2.5. Hemoglobin determination 
Hemoglobin accumulation was determined 
quantitatively by measuring the extinction of cyto- 
plasmic lysates at 540 nm (11.5 E$). The extinction 
of untreated cells at 540 nm have been subtracted. 
3. RESULTS 
3.1. Total NADH-cytochrome b5 reductase in non- 
induced and DMSO-treated MELC 
When MELC (clone 707 17C) are exposed to 
1.5% DMSO over 4 days, they exhibit an - 2-fold 
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increase of the specific activity of cytochrome b5 
reductase (table 1). When expressed per lo8 cells 
the increase of activity was 3-fold. The enzymatic 
activity of uninduced MELC was comparable (al- 
though not identical) to that found in reticulocytes 
and erythrocytes from DBA/2 mice. The activities 
of other enzymes such as glucose 6-phosphate de- 
hydrogenase and 6-phosphogluconate dehydro- 
genase were not modified by DMSO treatment. 
3.2. Time course of induction of total cytochrome 
b5 reductase activity in DMSO-treated MELC 
The enzyme activity was studied in MELC (clone 
707 17C) harvested at 2, 4 and 6 days in culture 
media containing 1.5% (v/v) DMSO and in control 
cultures without DMSO. The medium was not 
changed during the 6 day period. A difference in 
enzyme specific activity of Friend cells ( + 2 1 W) was 
detected after 2 days of DMSO treatment, when the 
cells were still actively proliferating (fig. 1). This in- 
crease became more pronounced (+ 76%) after 
4 days, when the culture entered stationary phase. 
After 6 days, when the majority of the cell popula- 
tion was synthesizing hemoglobin, the total cyto- 
chrome bS reductase specific activity was increased 
- 2-fold in DMSO-treated cells. The kinetics of this 
increase follows the kinetics of hemoglobin pro- 
duction and shows a good correlation between the 
two processes. The enzyme activities were also 
measured in a DMSO-resistant variant (clone TR 
25D) non-inducible for hemoglobin and spectrin 
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1131. After 2, 4 and 6 days of DMSO treatment of 
these cells the increase of cytochrome b5 reductase 
specific activity was I%, 18% and 24%, respective- 
ly. 
3.3. Subcellular distribution of cytochrmne b5 
reductuse activity in DMSU-treated MELC 
The 12 000 x g pellet exhibited marked increase 
of the specific activity after 2, 4 and 6 days of 
DMSO treatment of MELC (clone ‘707 I7C) (fig.2). 
The 800 x g and 105 000 x g membranous frac- 
tions also displayed a rise in enzymatic specific 
activities. In contrast, only a minor increase of the 
soluble cytosolic enzyme was noted; this soluble 
2 4 
Fig.]. Cytochrome bs reductase activity during 
DASH-treatment of MELC. Friend cells (clone 707 17Cf 
were grown in presence of 1.5% DMSO (v/v) and pellet- 
ed after 2, 4 and 6 days culture: (bf total activity 
(nmol . min - I . lo8 celk - I) after induction by DMSO; 
(A) total activity (nmol . min - 1 (I lo8 cells - ‘1 without 
DMSO; (s) specific activity (nmol. min - i . mg pro- 
tein- I) after DMSO induction; (o) specific activity 
(nmol . min- i . mg protein - ‘f without DMSO; ( +) 
hemoglobin induction. 
SO&j 
0 
‘Fig.2. Su~e~~uIar distribution of cytochrome Bs reduct- 
ase in MELC during DMSO-treatment. MELC (clone 
707 17C) were homogenized and fractionared as in sec- 
tion 2: (0) 800 X g pellet; ( + ) 12 000 X g pellet; (a) 
105 000 x g pellet; (A) cytosolic fraction. 
fraction corresponds to a very small fraction of the 
total activity (only - 6% of the total activity/lo8 
cells). To study the changes occurring during later 
stages of erythroid maturation, reticulocytes and 
erythrocytes of DBA/2 mice were prepared and 
enzyme activities measured as in section 2. The sol- 
uble and membranous forms of the enzyme in retic- 
ulocytes were found to be 43% and 57% of the 
enzymatic activity, respectively. in erythrocytes, the 
soluble enzyme corresponds to 69% and the mem- 
brane-bound enzyme to 3 1%. Thus, in reticulocytes 
and in adult erythrocytes, the proportion of soluble 
enzyme activity was much higher than in uninduced 
and DMSO-treated MELC. 
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4. DISCUSSION 
MELC are a favorable material to investigate the 
relationship between the ubiquitous membrane- 
bound cytochrome b5 reductase and its soluble 
counterpart which is characteristically elevated in 
circulating mature erythrocytes. Indeed, DMSO- 
treated MELC are known to progress from non- 
specialized erythroid cells analogous to pro- 
erythroblasts to specialized cells resembling ortho- 
chromatic erythroblasts. They express some of the 
properties of differentiating erythroid cells, such as 
synthesis of adult-type hemoglobin and some 
erythroid proteins [ 16-201. Membrane-bound 
redox proteins, particularly cytochrome bg, were 
shown in the T3Ll_2 MELC [21]. 
Our results provide evidence that MELC (clone 
707 17C) exhibit a cytochrome b5 reductase activity, 
which is increased - 3-fold (on a cellular basis) 
after erythroid differentiation in the presence of 
DMSO. This induction concerns exclusively the 
membrane-bound enzyme. The level of induction is 
comparable to that of other enzymes [ 16-201, while 
spectrin, hemoglobin and enzymes of the heme 
synthetic pathway are induced to a higher level. The 
timing of induction is similar to that of hemoglobin, 
therefore corresponding to a late program [19]. In 
[21], no increase of the membrane-bound cyto- 
chrome b5 was shown during the induction of an- 
other Friend cell line, clone T3Lt_2. In non-induced 
MELC, we found that the membrane-bound cyto- 
chrome b5 reductase activity was present in nuclear, 
mitochondrial and microsomal fractions, whereas 
very little activity was detected in the cytosol. In- 
duced MELC exhibited the same distribution, 
which indicates that the induction concerns only the 
membrane-bound enzyme. Moreover, during the 
induction, there is no release of the soluble form. 
This result agrees with [21], where no increase of 
soluble cytochrome 65 in induced MELC was 
found. We conclude that in immature erythroid 
cells, cytochrome bS reductase is essentially bound 
to membranes. DMSO-stimulated differentiation 
induces the membrane-bound enzyme activity and 
does not result in the ‘solubilization’ of cytochrome 
b5 reductase. We found that the induced MELC 
contain hemoglobin in the reduced state (not 
shown), while the soluble methemoglobin reduc- 
tion system (soluble cytochrome b5 and its reduct- 
ase) is not yet present. This suggests that the mem- 
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brane-bound system is functional with regard to the 
reduction of methemoglobin. In an acellular sys- 
tem, we also observed that methemoglobin is 
reduced by the endogenous membrane-bound 
enzyme and cytochrome b5 of MELC (not shown). 
Thus, the two membrane-bound proteins may con- 
stitute an active reducing system of methemoglobin 
in MELC. 
One of the limits of MELC model is that these 
cells rarely proceed in vitro to the non-nucleated 
stage of differentiation characteristic of normal 
erythropoiesis. Therefore, to determine the exact 
stage of solubilization of the membrane-bound 
cytochrome 65 reductase, the last step of erythroid 
maturation was studied. Reticulocytes and erythro- 
cytes were prepared from DBA/2 mice, from which 
Friend cells originated. Our results show that the 
respective values of the soluble enzyme were 6% of 
the total activity in Friend cells, 43% in reticulocytes 
and 69% in erythrocytes. 
We conclude that cytochrome b5 reductase is 
synthesized as a membrane-bound form during the 
proliferative phase of erythroid differentiation and 
that the soluble form is released by proteolysis 
occurring at a late stage of differentiation when 
most of the subcellular organelles of the late ortho- 
chromatophilic erythroblasts are degraded. Proteo- 
lytic activities have been reported in red cell [ 11,221 
and reticulocyte [22] membranes. The nature of the 
protease involved in this process remains to be 
elucidated. 
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